JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
JMP Securities Starts Mr. Cooper Group Inc. (COOP) at Market Outperform
-
JMP Securities Downgrades Paycor HCM Inc (PYCR) to Market Perform
-
Citizens M&A Outlook Finds Dealmaker Sentiment at a Five-Year High
-
JMP Securities Starts Context Therapeutics (CNTX) at Market Outperform
-
JMP Securities Upgrades LTC Properties (LTC) to Market Outperform
-
JMP Securities Upgrades Sabra Healthcare REIT Inc. (SBRA) to Market Outperform
-
Own these 3 internet stocks for 2025: JMP
-
Meta Platforms Inc. (META) PT Raised to $750 at JMP Securities
-
JMP Securities Downgrades Uber Inc. (UBER) to Market Perform
-
JMP Securities Downgrades Alphabet (GOOGL) to Market Perform
-
Joseph Rallo Scholarship for Entrepreneurs: Championing Innovation and Ambition Among Undergraduate Students
-
JMP Securities Reiterates Market Outperform Rating on FTAI Aviation (FTAI)
-
JMP Securities Upgrades Affirm Holdings Inc. (AFRM) to Market Outperform
-
JMP Securities Starts Blend Labs (BLND) at Market Outperform
-
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants
-
Reviva Pharmaceuticals (RVPH) Announces Proposed Share Offering
-
Reviva Announces Proposed Public Offering
-
JMP Securities Starts Addus HomeCare (ADUS) at Market Outperform
-
JMP Securities Starts U.S. Physical Therapy (USPH) at Market Outperform
-
Inovio Pharma (INO) Prices 10M Share Offering at $3/sh
-
INOVIO Announces Pricing of $30 Million Public Offering
-
Inovio Pharma (INO) Announces Proposed Share Offering
-
INOVIO Announces Proposed Public Offering
-
JMP Securities Downgrades Spruce Biosciences, Inc. (SPRB) to Market Perform
-
JMP Securities Downgrades Lava Therapeutics NV (LVTX) to Market Perform
-
JMP Securities Starts Solid Biosciences (SLDB) at Market Outperform
-
JMP Securities Starts Prime Medicine (PRME) at Market Outperform
-
Asana (ASAN) PT Raised to $25 at JMP Securities
-
Docusign Inc. (DOCU) PT Raised to $124 at JMP Securities
-
3 reasons why AVs are positive for Uber, not negative: JMP
-
JMP Securities Reiterates Market Outperform Rating on salesforce.com (CRM)
-
JMP Securities Starts Abivax (ABVX) at Market Outperform
-
Applied Digital (APLD) Closes $150M Senior Secured Note With Macquarie Equipment Capital
-
Applied Digital Closes $150 million Senior Secured Note With Macquarie Equipment Capital, Inc. to Refinance Existing Credit Facility With Former Senior Lender
-
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
-
Kura Oncology to Participate in JMP Securities Hematology and Oncology Summit
-
JMP Securities Downgrades Expensify Inc (EXFY) to Market Perform
-
Chesapeake Utilities Corporation Announces $100 Million At-The-Market Equity Offering Program
-
Lemonade Inc. (LMND) PT Raised to $60 at JMP Securities
-
JMP Securities Downgrades Root, Inc. (ROOT) to Market Perform
-
JMP Securities Starts Engene Holdings Inc. (ENGN) at Market Outperform
-
JMP Securities Starts Penguin Solutions (PENG) at Market Outperform
-
Salesforce (CRM) Edges Lower Following Report AI Executive Departs
-
JMP Securities Downgrades Syros Pharmaceuticals (SYRS) to Market Perform
-
Safehold Announces Pricing of $400 Million of Senior Unsecured Notes Due 2035
-
Robinhood Markets (HOOD) PT Raised to $40 at JMP Securities
-
JMP Securities Downgrades agilon health Inc (AGL) to Market Perform
-
PRA Group to Present at Upcoming November and December 2024 Investor Conferences
-
JMP Securities Downgrades Nerdy (NRDY) to Market Perform
-
Pacira BioSciences Reports Third Quarter 2024 Financial Results

